Gilead Sciences Inc. (NASDAQ: GILD) announced it will acquire Tubulis GmbH, a Germany-based clinical-stage biotechnology company developing antibody-drug conjugates for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions